PATRICK GAGNON: Open Payments
NPI 1083748214 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 32 payments from 16 companies in 2025. Trend: 2023 $4,073 · 2024 $3,754 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $250 |
| TMS NeuroHealth Centers Inc. | 1 | $144 |
| ABBVIE INC. | 1 | $125 |
| SCILEX PHARMACEUTICALS INC. | 5 | $105 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Lundbeck LLC | 3 | $61 |
| Amgen Inc. | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $28 |
Products named: Auvelity, TMS NeuroHealth Centers Inc., VRAYLAR, ZTLido, XIFAXAN, Kerendia, ABILIFY ASIMTUFII, FANAPT.
Industry payments across CT — which companies pay providers there.
